这是一篇来自已证抗体库的有关人类 PDCD4的综述,是根据27篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PDCD4 抗体。
PDCD4 同义词: H731

艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6a, 6c
艾博抗(上海)贸易有限公司 PDCD4抗体(Abcam, ab51495)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a, 6c). Int J Oncol (2020) ncbi
domestic rabbit 单克隆
  • 免疫印迹; 人类; 图 e8s
艾博抗(上海)贸易有限公司 PDCD4抗体(Abcam, ab79405)被用于被用于免疫印迹在人类样本上 (图 e8s). Nature (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s2
艾博抗(上海)贸易有限公司 PDCD4抗体(Abcam, ab51495)被用于被用于免疫印迹在小鼠样本上 (图 s2). Cardiovasc Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 PDCD4抗体(Abcam, ab51495)被用于被用于免疫印迹在人类样本上 (图 1). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit 单克隆(EPR3431)
  • 免疫印迹; 人类; 图 3
艾博抗(上海)贸易有限公司 PDCD4抗体(Abcam, ab80590)被用于被用于免疫印迹在人类样本上 (图 3). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(EPR3431)
  • 免疫印迹; 人类; 图 5
艾博抗(上海)贸易有限公司 PDCD4抗体(Abcam, ab80590)被用于被用于免疫印迹在人类样本上 (图 5). Cell Death Dis (2015) ncbi
Rockland Immunochemicals
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4a
Rockland Immunochemicals PDCD4抗体(Rockland Immunochemicals, 600-401-965)被用于被用于免疫印迹在人类样本上 (图 4a). Cell Rep (2018) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
Rockland Immunochemicals PDCD4抗体(Rockland, 600-401-965)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
小鼠 单克隆(9G6)
  • 免疫印迹; 小鼠; 图 3a
Rockland Immunochemicals PDCD4抗体(Rockland Immunochemicals, 9G6)被用于被用于免疫印迹在小鼠样本上 (图 3a). Cell Death Differ (2017) ncbi
domestic rabbit 多克隆
  • reverse phase protein lysate microarray; 人类; 图 st6
Rockland Immunochemicals PDCD4抗体(Rockland, 600-401-965)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 多克隆
  • reverse phase protein lysate microarray; 人类; 图 3a
Rockland Immunochemicals PDCD4抗体(Rockland, 600-401-965)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 3a). Nature (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5
Rockland Immunochemicals PDCD4抗体(Rockland, 600-401-965)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(k4C1)
  • 免疫印迹; 人类; 图 4d
圣克鲁斯生物技术 PDCD4抗体(Santa Cruz, sc-130545)被用于被用于免疫印迹在人类样本上 (图 4d). Mol Cancer (2017) ncbi
小鼠 单克隆(k4C1)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 PDCD4抗体(santa Cruz, sc-130545)被用于被用于免疫印迹在人类样本上 (图 4). Protein Cell (2016) ncbi
小鼠 单克隆(k4C1)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 PDCD4抗体(santa Cruz, sc-130545)被用于被用于免疫印迹在人类样本上 (图 1). Sci Rep (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠; 1:1000; 图 s8a
赛信通(上海)生物试剂有限公司 PDCD4抗体(CST, 9535)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s8a). Cancers (Basel) (2021) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠; 图 3h
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, 9535T)被用于被用于免疫印迹在小鼠样本上 (图 3h). Adv Sci (Weinh) (2021) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠; 图 6d
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, D29C6)被用于被用于免疫印迹在小鼠样本上 (图 6d). Oncogene (2018) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, D29C6)被用于被用于免疫印迹在小鼠样本上 (图 3a). Cell Death Differ (2017) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠; 图 6d
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, 9535S)被用于被用于免疫印迹在小鼠样本上 (图 6d). Oncogene (2017) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫细胞化学; 小鼠; 1:300; 图 3
  • 免疫印迹; 小鼠; 1:1000; 图 5
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, 9535)被用于被用于免疫细胞化学在小鼠样本上浓度为1:300 (图 3) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, 9535S)被用于被用于免疫印迹在人类样本上 (图 5a). Int J Mol Med (2016) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 人类; 图 4d
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, 9535)被用于被用于免疫印迹在人类样本上 (图 4d). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫细胞化学; 人类; 1:500; 图 7a
  • 免疫印迹; 人类; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell signaling, 9535)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 7a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling Technology, 9535P)被用于被用于免疫印迹在人类样本上. J Biol Chem (2015) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫沉淀; 人类
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling Technology, 9535)被用于被用于免疫沉淀在人类样本上. J Proteome Res (2015) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling Tech, 9535)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(D29C6)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 PDCD4抗体(Cell Signaling, D29C6)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Carcinogenesis (2013) ncbi
文章列表
  1. Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clement S, Maeder C, et al. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021;13: pubmed 出版商
  2. Tan H, Song Y, Chen J, Zhang N, Wang Q, Li Q, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8:e2100787 pubmed 出版商
  3. Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M, et al. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway. Int J Oncol. 2020;56:178-192 pubmed 出版商
  4. Wang J, Liu Y, Liu Y, Zheng S, Wang X, Zhao J, et al. Time-resolved protein activation by proximal decaging in living systems. Nature. 2019;569:509-513 pubmed 出版商
  5. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed 出版商
  6. Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar M, et al. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. Oncogene. 2018;37:3151-3165 pubmed 出版商
  7. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  8. Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 2017;24:1739-1749 pubmed 出版商
  9. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed 出版商
  10. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  11. Liu Y, Liu R, Yang F, Cheng R, Chen X, Cui S, et al. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Mol Cancer. 2017;16:53 pubmed 出版商
  12. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed 出版商
  13. Bai Y, Dong Z, Shang Q, Zhao H, Wang L, Guo C, et al. Pdcd4 Is Involved in the Formation of Stress Granule in Response to Oxidized Low-Density Lipoprotein or High-Fat Diet. PLoS ONE. 2016;11:e0159568 pubmed 出版商
  14. Li Y, Jiang D, Zhang Q, Liu X, Cai Z. Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4. Int J Mol Med. 2016;38:803-11 pubmed 出版商
  15. Zhu K, Liu L, Zhang J, Wang Y, Liang H, Fan G, et al. MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6. Protein Cell. 2016;7:434-44 pubmed 出版商
  16. Liang H, Wang F, Chu D, Zhang W, Liao Z, Fu Z, et al. miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma. Sci Rep. 2016;6:23772 pubmed 出版商
  17. Gupta S, Itagaki R, Zheng X, Batkai S, Thum S, Ahmad F, et al. miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. Cardiovasc Res. 2016;110:215-26 pubmed 出版商
  18. Park S, Jeong S. SRSF3 represses the expression of PDCD4 protein by coordinated regulation of alternative splicing, export and translation. Biochem Biophys Res Commun. 2016;470:431-438 pubmed 出版商
  19. Jin Y, Andrade J, Wickstrom E. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity. PLoS ONE. 2015;10:e0142574 pubmed 出版商
  20. Liwak Muir U, Dobson C, Naing T, Wylie Q, Chehade L, Baird S, et al. ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism. Oncotarget. 2016;7:1439-50 pubmed 出版商
  21. Schipany K, Rosner M, Ionce L, Hengstschläger M, Kovacic B. eIF3 controls cell size independently of S6K1-activity. Oncotarget. 2015;6:24361-75 pubmed
  22. Maachani U, Tandle A, Shankavaram U, Kramp T, Camphausen K. Modulation of miR-21 signaling by MPS1 in human glioblastoma. Oncotarget. 2016;7:52912-52927 pubmed 出版商
  23. Teng Y, Radde B, Litchfield L, Ivanova M, Prough R, Clark B, et al. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells. J Biol Chem. 2015;290:15799-811 pubmed 出版商
  24. Xu H, Dephoure N, Sun H, Zhang H, Fan F, Liu J, et al. Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4. J Proteome Res. 2015;14:2480-91 pubmed 出版商
  25. Modelska A, Turro E, Russell R, Beaton J, Sbarrato T, Spriggs K, et al. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape. Cell Death Dis. 2015;6:e1603 pubmed 出版商
  26. Galicia Vázquez G, Di Marco S, Lian X, Ma J, Gallouzi I, Pelletier J. Regulation of eukaryotic initiation factor 4AII by MyoD during murine myogenic cell differentiation. PLoS ONE. 2014;9:e87237 pubmed 出版商
  27. Ma X, Choudhury S, Hua X, Dai Z, Li Y. Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway. Carcinogenesis. 2013;34:1216-23 pubmed 出版商